Fe Pharmaceuticals Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

Fe Pharmaceuticals General Information

Description

Developer of a therapeutic drug designed for the management and control of bacterial and fungal infections, including those resistant to antibiotics. The company offers ultra-potent, non-toxic, iron-binding polymers that also blunt the cytokine storm associated with sepsis morbidity and mortality, inhibit the growth of cancer cells, and enhance the potency of existing chemotherapeutics, enabling the medical community to control infections caused by bacterial and fungal pathogens without fear of resistance emerging.

Contact Information

Website
www.fepharm.com
Formerly Known As
Chelation Partners
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • The Labs at Innovacorp, Life Sciences Research Institute 1344 Summer Street
  • Suite 58
  • Halifax, Nova Scotia B3H 0A8
  • Canada
+1 (902)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • The Labs at Innovacorp, Life Sciences Research Institute 1344 Summer Street
  • Suite 58
  • Halifax, Nova Scotia B3H 0A8
  • Canada
+1 (902)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fe Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private 01-Feb-2026 Completed Pre-Clinical Trials
8. Seed Round 25-Apr-2023 Completed Pre-Clinical Trials
7. Accelerator/Incubator 29-Oct-2021 Completed Startup
6. Angel (individual) 24-Feb-2020 Completed Startup
5. Angel (individual) Completed Startup
4. Grant 11-Feb-2014 Completed Startup
3. Grant 17-May-2012 Completed Startup
2. Angel (individual) Completed Startup
1. Accelerator/Incubator Completed Startup
To view Fe Pharmaceuticals’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Fe Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a therapeutic drug designed for the management and control of bacterial and fungal infections, including th
Drug Discovery
Halifax, Canada
6 As of 2025

Sydney, Australia
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Fe Pharmaceuticals Competitors (1)

One of Fe Pharmaceuticals’s competitors is Recce Pharmaceuticals, a Corporation company based in Sydney, Australia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Recce Pharmaceuticals Corporation Sydney, Australia
You’re viewing 1 of 1 competitors. Get the full list »

Fe Pharmaceuticals Patents

Fe Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017314880-A1 Polymeric metal chelating compositions and methods of preparing same for controlling growth and activities of living cells and organisms Active 26-Aug-2016
AU-2017314880-B2 Polymeric metal chelating compositions and methods of preparing same for controlling growth and activities of living cells and organisms Active 26-Aug-2016
AU-2021204603-A1 Polymeric metal chelating compositions and methods of preparing same for controlling growth and activities of living cells and organisms Active 26-Aug-2016
AU-2021204603-B2 Polymeric metal chelating compositions and methods of preparing same for controlling growth and activities of living cells and organisms Active 26-Aug-2016
CA-3034540-A1 Polymeric metal chelating compositions and methods of preparing same for controlling growth and activities of living cells and organisms Pending 26-Aug-2016 C07D213/69
To view Fe Pharmaceuticals’s complete patent history, request access »

Fe Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fe Pharmaceuticals Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Invest Nova Scotia Venture Capital Minority
Canadian Entrepreneurs in Life Science Accelerator/Incubator
Atlantic Canada Opportunities Agency Government
To view Fe Pharmaceuticals’s complete investors history, request access »

Fe Pharmaceuticals FAQs

  • When was Fe Pharmaceuticals founded?

    Fe Pharmaceuticals was founded in 2012.

  • Where is Fe Pharmaceuticals headquartered?

    Fe Pharmaceuticals is headquartered in Halifax, Canada.

  • What is the size of Fe Pharmaceuticals?

    Fe Pharmaceuticals has 6 total employees.

  • What industry is Fe Pharmaceuticals in?

    Fe Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Fe Pharmaceuticals a private or public company?

    Fe Pharmaceuticals is a Private company.

  • What is Fe Pharmaceuticals’s current revenue?

    The current revenue for Fe Pharmaceuticals is .

  • How much funding has Fe Pharmaceuticals raised over time?

    Fe Pharmaceuticals has raised $2.34M.

  • Who are Fe Pharmaceuticals’s investors?

    Invest Nova Scotia, Canadian Entrepreneurs in Life Science, and Atlantic Canada Opportunities Agency have invested in Fe Pharmaceuticals.

  • Who are Fe Pharmaceuticals’s competitors?

    Recce Pharmaceuticals is a competitor of Fe Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process